JP5744517B2 - マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法 - Google Patents

マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法 Download PDF

Info

Publication number
JP5744517B2
JP5744517B2 JP2010522676A JP2010522676A JP5744517B2 JP 5744517 B2 JP5744517 B2 JP 5744517B2 JP 2010522676 A JP2010522676 A JP 2010522676A JP 2010522676 A JP2010522676 A JP 2010522676A JP 5744517 B2 JP5744517 B2 JP 5744517B2
Authority
JP
Japan
Prior art keywords
microneedle
coating
japanese encephalitis
encephalitis virus
virus antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2010522676A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2010013601A1 (ja
Inventor
周英 野崎
周英 野崎
一義 上仲
一義 上仲
松田　純一
純一 松田
寺原　孝明
孝明 寺原
哲治 桑原
哲治 桑原
誠治 徳本
誠治 徳本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken, Hisamitsu Pharmaceutical Co Inc filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP2010522676A priority Critical patent/JP5744517B2/ja
Publication of JPWO2010013601A1 publication Critical patent/JPWO2010013601A1/ja
Application granted granted Critical
Publication of JP5744517B2 publication Critical patent/JP5744517B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
JP2010522676A 2008-07-30 2009-07-16 マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法 Active JP5744517B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010522676A JP5744517B2 (ja) 2008-07-30 2009-07-16 マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2008197064 2008-07-30
JP2008197064 2008-07-30
PCT/JP2009/062887 WO2010013601A1 (ja) 2008-07-30 2009-07-16 マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法
JP2010522676A JP5744517B2 (ja) 2008-07-30 2009-07-16 マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法

Publications (2)

Publication Number Publication Date
JPWO2010013601A1 JPWO2010013601A1 (ja) 2012-01-12
JP5744517B2 true JP5744517B2 (ja) 2015-07-08

Family

ID=41610300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010522676A Active JP5744517B2 (ja) 2008-07-30 2009-07-16 マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法

Country Status (4)

Country Link
JP (1) JP5744517B2 (ko)
KR (1) KR101622738B1 (ko)
CN (1) CN102112151A (ko)
WO (1) WO2010013601A1 (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101746747B1 (ko) 2016-03-03 2017-06-14 배원규 모세관력을 이용하여 약물의 전달성을 향상시킨 마이크로니들 시스템

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458359B (zh) 2009-06-10 2015-01-28 久光制药株式会社 微针装置
US20140037694A1 (en) * 2011-02-25 2014-02-06 Hisamitsu Pharmaceutical Co., Inc. Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing same
JP6175485B2 (ja) * 2013-02-13 2017-08-02 久光製薬株式会社 マイクロニードルコーティング用組成物及びマイクロニードルデバイス
JP6246784B2 (ja) * 2013-02-13 2017-12-13 久光製薬株式会社 マイクロニードルコーティング用組成物及びマイクロニードルデバイス
JP6114401B2 (ja) * 2013-10-31 2017-04-12 久光製薬株式会社 アジュバント組成物、これを含むアジュバント製剤、及びキット
KR102139336B1 (ko) * 2015-04-20 2020-07-29 주식회사 엘지생활건강 유효 성분의 흡수속도가 개선된 용해성 마이크로니들 디바이스 및 이를 포함하는 키트
CN110114069B (zh) * 2016-12-26 2022-03-04 久光制药株式会社 微针装置

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001076624A1 (fr) * 2000-04-07 2001-10-18 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccin inactive contre l'encephalite japonaise b et procede d'elaboration associe
WO2007012114A1 (en) * 2005-07-25 2007-02-01 Nanotechnology Victoria Pty Ltd Microarray device
WO2007015441A1 (ja) * 2005-08-01 2007-02-08 Hisamitsu Pharmaceutical Co., Inc. 経皮または経粘膜投与のためのアジュバントおよび製剤
WO2007116959A1 (ja) * 2006-04-07 2007-10-18 Hisamitsu Pharmaceutical Co., Inc. マイクロニードルデバイスおよびマイクロニードル付き経皮薬物投与装置
JP2008074763A (ja) * 2006-09-21 2008-04-03 Nitto Denko Corp 糖材料の調製方法ならびに糖材料、糖材料を含むマイクロニードルおよびマイクロニードルをそなえてなる経皮製剤
JP2008519042A (ja) * 2004-11-03 2008-06-05 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド インフルエンザワクチン接種

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309650B1 (en) * 1997-08-28 2001-10-30 Cheil Jedang Corporation Attenuated Japanese encephalitis virus adapted to Vero cell and a Japanese encephalitis vaccine
WO2005099751A2 (en) * 2004-04-01 2005-10-27 Alza Corporation Apparatus and method for transdermal delivery of influenza vaccine

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001076624A1 (fr) * 2000-04-07 2001-10-18 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccin inactive contre l'encephalite japonaise b et procede d'elaboration associe
JP2008519042A (ja) * 2004-11-03 2008-06-05 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド インフルエンザワクチン接種
WO2007012114A1 (en) * 2005-07-25 2007-02-01 Nanotechnology Victoria Pty Ltd Microarray device
WO2007015441A1 (ja) * 2005-08-01 2007-02-08 Hisamitsu Pharmaceutical Co., Inc. 経皮または経粘膜投与のためのアジュバントおよび製剤
WO2007116959A1 (ja) * 2006-04-07 2007-10-18 Hisamitsu Pharmaceutical Co., Inc. マイクロニードルデバイスおよびマイクロニードル付き経皮薬物投与装置
JP2008074763A (ja) * 2006-09-21 2008-04-03 Nitto Denko Corp 糖材料の調製方法ならびに糖材料、糖材料を含むマイクロニードルおよびマイクロニードルをそなえてなる経皮製剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101746747B1 (ko) 2016-03-03 2017-06-14 배원규 모세관력을 이용하여 약물의 전달성을 향상시킨 마이크로니들 시스템

Also Published As

Publication number Publication date
WO2010013601A1 (ja) 2010-02-04
JPWO2010013601A1 (ja) 2012-01-12
CN102112151A (zh) 2011-06-29
KR101622738B1 (ko) 2016-05-19
KR20110036907A (ko) 2011-04-12

Similar Documents

Publication Publication Date Title
KR101578420B1 (ko) 마이크로니들 디바이스 및 마이크로니들 디바이스에 의한 인플루엔자 백신의 주공성을 상승시키는 방법
JP5744517B2 (ja) マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法
Li et al. A solid polymer microneedle patch pretreatment enhances the permeation of drug molecules into the skin
EP2119469B1 (en) Microneedle device for diagnosis of allergy
RU2630610C2 (ru) Трансдермальная доставка высоковязких биоактивных агентов
Chen et al. Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination
Garland et al. Microneedle arrays as medical devices for enhanced transdermal drug delivery
RU2494769C2 (ru) Массив полых микроигл и способ его использования
TWI625128B (zh) Microneedle coating composition and microneedle device
KR20050054483A (ko) 코팅된 미세돌출부를 갖는 경피용 약물 전달 장치
US20200147209A1 (en) Alum-containing coating formulations for microneedle vaccine patches
JP2006516205A (ja) 被覆された微小突起を有する経皮ワクチン送達装置
KR20040014502A (ko) 미세돌출부 어레이 면역 패취 및 방법
JP2011172968A (ja) 有益な作用物質を含有するコーティングを有する微小突起アレイ
Parhi et al. Review of microneedle based transdermal drug delivery systems
More et al. Microneedle: an advanced technique in transdermal drug delivery system
Umeyor et al. Biomimetic microneedles: Exploring the recent advances on a microfabricated system for precision delivery of drugs, peptides, and proteins
Naik et al. Drug Delivery Through Microneedles for Improved Permeability and Efficacy: Fabrication, Methodology and Applications
Kulkarni et al. The microneedle patches: an innovative approach
JP2009072270A (ja) マイクロニードルチップ
Cheung et al. Microneedles for drug delivery: trends and progress.
Jagtap et al. A review: transdermal microneedle
Zhang et al. Coated Porous Microneedles for Effective Intradermal Immunization with Split Influenza Vaccine
Ravi et al. A comprehensive review on microneedles-an archetype swing in transdermal drug delivery
Rathor et al. Advancement in transdermal drug delivery system: Microneedles

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120312

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130709

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130904

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140703

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150327

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20150421

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20150430

R150 Certificate of patent or registration of utility model

Ref document number: 5744517

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250